These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23325039)

  • 1. Pentatrichomonas hominis infection in rheumatoid arthritis treated with adalimumab.
    Compaoré C; Kemta Lekpa F; Nebie L; Niamba P; Niakara A
    Rheumatology (Oxford); 2013 Aug; 52(8):1534-5. PubMed ID: 23325039
    [No Abstract]   [Full Text] [Related]  

  • 2. Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Flendrie M; den Broeder AA; Visser H; Hartkamp A; van de Laar MA; van Riel PL
    Ann Rheum Dis; 2013 Jun; 72(6):895-900. PubMed ID: 22887849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review.
    Tung Chen Y; Perales C; Lacruz J; Senent L; Salavert M
    Int J Rheum Dis; 2014 Sep; 17(7):822-4. PubMed ID: 24980576
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
    Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
    Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three Pentatrichomonas hominis Cases Presenting with Gastrointestinal Symptoms.
    Doğan N; Tüzemen NÜ
    Turkiye Parazitol Derg; 2018 Jun; 42(2):168-170. PubMed ID: 30070647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium chelonae infection in a patient being treated with adalimumab.
    Conejero R; Ara M; Lorda M; Rivera I
    Actas Dermosifiliogr; 2012 Jan; 103(1):69-71. PubMed ID: 22464598
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of tuberculous peritonitis in the United States in a patient with rheumatoid arthritis treated with adalimumab.
    Szeto T; Peterson J; Silva F
    J Clin Rheumatol; 2010 Apr; 16(3):135-7. PubMed ID: 20375825
    [No Abstract]   [Full Text] [Related]  

  • 8. Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.
    Schabert VF; Bruce B; Ferrufino CF; Globe DR; Harrison DJ; Lingala B; Fries JF
    Curr Med Res Opin; 2012 Apr; 28(4):569-80. PubMed ID: 22236091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal tuberculosis in a patient on infliximab treatment.
    Karagiannis S; Papaioannou D; Goulas S; Psilopoulos D; Mavrogiannis C
    Gastrointest Endosc; 2008 Jun; 67(7):1178-9; discussion 1179. PubMed ID: 18329027
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated primary varicella infection during infliximab treatment.
    Vonkeman H; ten Napel C; Rasker H; van de Laar M
    J Rheumatol; 2004 Dec; 31(12):2517-8. PubMed ID: 15570661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.
    Krieckaert CL; Jamnitski A; Nurmohamed MT; Kostense PJ; Boers M; Wolbink G
    Arthritis Rheum; 2012 Dec; 64(12):3850-5. PubMed ID: 22933315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.
    van Vollenhoven RF; Fleischmann R; Cohen S; Lee EB; García Meijide JA; Wagner S; Forejtova S; Zwillich SH; Gruben D; Koncz T; Wallenstein GV; Krishnaswami S; Bradley JD; Wilkinson B;
    N Engl J Med; 2012 Aug; 367(6):508-19. PubMed ID: 22873531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.
    True DG; Penmetcha M; Peckham SJ
    J Rheumatol; 2002 Jul; 29(7):1561-3. PubMed ID: 12136922
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
    Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
    Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trichomonas vaginalis infection in the male].
    Haschek H; Kofler K
    Med Klin; 1973 Jan; 68(4):106-10. PubMed ID: 4567799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab: a case description and literature review].
    Moreno D; Martínez P; Berbegal J; Femenia M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):261-2. PubMed ID: 19729230
    [No Abstract]   [Full Text] [Related]  

  • 18. [Symptomatology and therapy of female and male trichomoniasis].
    Walther H
    Ther Ggw; 1966 Jul; 105(7):886-9. PubMed ID: 5923788
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trichomonas infection in clinical picture, therapy and significance to fertility and sterility].
    Walther H
    Z Hautkr; 1973 Jul; 48(14):553-62. PubMed ID: 4784128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trichomoniasis].
    Fritjofsson A
    Lakartidningen; 1965 Sep; 62(35):2706. PubMed ID: 5868087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.